60 Tabs — 600 mcg
Uptravi (selexipag) is a medication used to treat pulmonary arterial hypertension (PAH) by lowering the blood pressure in the pulmonary arteries, allowing for easier breathing and improved exercise ability.
Uptravi (selexipag) is an oral medication prescribed by doctors to treat pulmonary arterial hypertension (PAH). PAH is a rare, serious condition that can lead to heart failure and other serious health risks. Uptravi helps relax and widen the blood vessels in the lungs, improving blood flow and decreasing the workload of the heart. It is the only product in its class that has been clinically proven to reduce the risk of hospitalization due to PAH. Uptravi can be taken with or without food, making it easy to fit into your daily routine. With Uptravi, you can be assured that your PAH is being taken care of and that you are closer to living a life free of hospitalizations.